USD 0.1
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 32.26 Thousand | - | - | - | - | - |
Cost of Revenue | 32.26 Thousand | - | - | - | 5.38 | 428.04 Thousand |
Gross Profit | - | - | - | - | -5.38 | -428.04 Thousand |
Operating Expenses | 284.38 Thousand | 312.66 Thousand | 300.37 Thousand | 120.34 Thousand | 374.15 Thousand | 3.91 Million |
Selling, General and Administrative Expenses | 250.75 Thousand | 312.66 Thousand | 300.37 Thousand | 120.34 Thousand | 368.77 Thousand | 3.48 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | -5376.00 | -411.72 Thousand |
Cost and Expenses | 316.64 Thousand | 312.66 Thousand | 300.37 Thousand | 120.34 Thousand | 374.15 Thousand | 3.91 Million |
Operating Income | -284.03 Thousand | -306.28 Thousand | -306.6 Thousand | -154.18 Thousand | -374.15 Thousand | -3.91 Million |
Interest Expense | - | - | - | - | - | 11.98 Thousand |
Income Tax Expense | 1283.96 | 6122.72 | -6504.31 | -33.95 Thousand | -787.26 | -775.27 Thousand |
Earnings before Tax | -316.64 Thousand | -319.04 Thousand | -294.14 Thousand | -86.5 Thousand | 19.21 Thousand | -4.71 Million |
Net Income | -318.21 Thousand | -319.04 Thousand | -294.14 Thousand | -86.5 Thousand | 19.21 Thousand | -4.71 Million |
Earnings Per Share Basic | -0.06 | -0.10 | -0.16 | -0.08 | 0.02 | -4.75 |
Earnings Per Share Diluted | -0.06 | -0.10 | -0.16 | -0.08 | 0.02 | -4.24 |
Weighted Average Shares Outstanding | 5.1 Million | 3.27 Million | 1.86 Million | 1.15 Million | 1.15 Million | 992.51 Thousand |
Weighted Average Shares Outstanding (Diluted) | 5.1 Million | 3.27 Million | 1.86 Million | 1.15 Million | 1.15 Million | 1.11 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | -1.01 | - | - | - | - | - |
Profit Margin | -9.86 | - | - | - | - | - |
EBITDA | -32.6 Thousand | -306.28 Thousand | -306.6 Thousand | -154.18 Thousand | -374.15 Thousand | -3.91 Million |
Earnings Before Tax Margin | -8.80 | - | - | - | - | - |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | 32.26 | - |
Gross Profit | - | - | - | - | -32.26 | - |
Operating Expenses | 186.47 Thousand | 181.68 Thousand | 66.91 Thousand | 76.27 Thousand | 312.21 Thousand | 67.49 Thousand |
Selling, General and Administrative Expenses | 186.47 Thousand | 181.68 Thousand | 66.91 Thousand | 76.27 Thousand | - | 49.76 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 92.6 Thousand | - | - | - | - | - |
Cost and Expenses | 186.47 Thousand | 181.68 Thousand | 66.91 Thousand | 76.27 Thousand | 312.21 Thousand | 67.49 Thousand |
Operating Income | -186.47 Thousand | -181.69 Thousand | -66.92 Thousand | -76.28 Thousand | -312.22 Thousand | -67.49 Thousand |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | -173.49 Thousand | -171.14 | -63.13 | 1492.42 | 1283.96 | -46.76 |
Earnings before Tax | -184.1 Thousand | -183.89 Thousand | -64.81 Thousand | -80.7 Thousand | -316.64 Thousand | -67.49 Thousand |
Net Income | -184.1 Thousand | -183.89 Thousand | -64.81 Thousand | -82.27 Thousand | -318.21 Thousand | -67.49 Thousand |
Earnings Per Share Basic | -0.01 | -0.02 | -0.01 | -0.02 | - | -0.01 |
Earnings Per Share Diluted | -0.01 | -0.02 | -0.01 | -0.02 | - | -0.01 |
Weighted Average Shares Outstanding | 14.4 Million | 10.66 Million | 5.1 Million | 5.1 Million | 5.1 Million | 9.36 Million |
Weighted Average Shares Outstanding (Diluted) | 14.4 Million | 10.66 Million | 5.1 Million | 5.1 Million | 5.1 Million | 9.36 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -186.47 Thousand | -181.69 Thousand | -66.92 Thousand | -76.28 Thousand | - | -67.49 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
STAR
2459
6456
WOCKPHARMA
ASBFY
PEB